Related Experiment Video
Updated: May 30, 2026
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?
Astrid Jüngel1, Jörg H W Distler, Steffen Gay
1Center of Experimental Rheumatology, University Hospital Zurich, Zurich Center of Integrative Human Physiology, Switzerland.
Expert Review of Clinical Immunology
|July 28, 2011
Summary
Epigenetic modifications, including DNA methylation and histone modifications, drive fibroblast activation in systemic sclerosis. Epigenetic drugs can reverse this activated phenotype, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Epigenetics
- Dermatology
Background:
- Gene expression is regulated by epigenetic modifications like DNA methylation and histone modifications.
- Aberrant epigenetic regulation can lead to diseases such as cancer and autoimmune disorders.
- Systemic sclerosis is characterized by excessive extracellular matrix production in skin fibroblasts.
Purpose of the Study:
- To investigate the role of epigenetic modifications in the activated phenotype of systemic sclerosis fibroblasts.
- To determine if epigenetic-based drugs can reverse the activated phenotype in these cells.
Main Methods:
- Analysis of DNA methylation patterns in systemic sclerosis fibroblasts.
- Assessment of histone modification levels and their impact on gene expression.
- In vitro and in vivo experiments using epigenetic-modifying drugs.
Main Results:
- Epigenetic modifications, including DNA methylation and histone modifications, were found to contribute to the activated phenotype of systemic sclerosis fibroblasts.
- These modifications were associated with massive production of extracellular matrix proteins.
- Treatment with epigenetic-based drugs reversed the activated fibroblast phenotype in both in vitro and in vivo models.
Conclusions:
- Epigenetic modifications play a crucial role in the pathogenesis of systemic sclerosis by driving fibroblast activation and extracellular matrix overproduction.
- Epigenetic therapies hold promise for reversing the disease phenotype in systemic sclerosis.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.